» Authors » Nikolaos Georgiadis

Nikolaos Georgiadis

Explore the profile of Nikolaos Georgiadis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 571
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Proikaki S, Georgiadis N, Sergentanis T, Kornarou E, Vassilakou T
Diseases . 2025 Feb; 13(2). PMID: 39997063
Background: The interaction between HIV infection, nutrition and immune system functioning is intricate, leading, in many cases, to a cycle of poor health outcomes. Despite the widespread use of highly...
2.
Georgiadis N, Papamichail D, Lytras T, Halkitis P, Tzanakaki G, Kornarou E, et al.
AIDS . 2024 Apr; 38(7):1033-1045. PMID: 38669203
Objective: To evaluate the effect of preexposure prophylaxis (PrEP) initiation on bacterial sexually transmitted infection (STI) occurrence (overall; chlamydia; gonorrhea; syphilis), in MSM. Design: Systematic review and meta-analysis. Methods: Systematic...
3.
Toumanidou V, Diafas A, Georgiadis N, Tsinopoulos I
J Clin Med . 2023 May; 12(9). PMID: 37176579
Purpose: To investigate the effect of fixed combination versus concomitant unfixed topical glaucoma treatment on patients' adherence and ocular surface health. Patients And Methods: This is a 6-month, prospective, parallel-group,...
4.
Katsimpris A, Voulgari N, Georgiadis N, Kandarakis S
Rom J Ophthalmol . 2023 Apr; 67(1):41-45. PMID: 37089795
The implementation of guideline recommendations for antibiotics prescription for the management of patients with acute infective conjunctivitis (AIC) in primary care departments remains below par. Our objective was to assess...
5.
Georgiadis N, Tsarouhas K, Dorne J, Kass G, Laspa P, Toutouzas K, et al.
J Cardiovasc Dev Dis . 2022 Jul; 9(7). PMID: 35877588
(1) Background: Human health risks and hazards from chemical substances are well regulated internationally. However, cardiotoxicity, is not defined as a stand-alone hazard and therefore there are no defined criteria...
6.
Tsitsimpikou C, Georgiadis N, Tsarouhas K, Kartsidis P, Foufa E, Bacopoulou F, et al.
Int J Environ Res Public Health . 2021 Dec; 18(24). PMID: 34948557
Over the last decades, human activities prompted the high production and widespread use of household chemical products, leading to daily exposure of humans to several chemicals. The objective of this...
7.
Georgiadis N, Tsarouhas K, Rezaee R, Nepka H, Kass G, Dorne J, et al.
Oncol Rep . 2020 Sep; 44(4):1772. PMID: 32945511
Subsequently to the publication of this paper, the authors have realized that the name of the seventh listed author, Dimitrios Stagos, was spelt incorrectly (it appeared as 'Stagkos' in print)....
8.
Georgiadis N, Tsarouhas K, Rezaee R, Nepka H, Kass G, Dorne J, et al.
Oncol Rep . 2020 Jul; 44(3):798-818. PMID: 32705236
Anthracyclines are commonly used anticancer drugs with well‑known and extensively studied cardiotoxic effects in humans. In the clinical setting guidelines for assessing cardiotoxicity are well‑established with important therapeutic implications. Cardiotoxicity...
9.
Hardy A, Benford D, Halldorsson T, Jeger M, Knutsen H, More S, et al.
EFSA J . 2020 Jul; 15(8):e04971. PMID: 32625632
EFSA requested the Scientific Committee to develop a guidance document on the use of the weight of evidence approach in scientific assessments for use in all areas under EFSA's remit....
10.
Hardy A, Benford D, Halldorsson T, Jeger M, Knutsen H, More S, et al.
EFSA J . 2020 Jul; 15(8):e04970. PMID: 32625631
EFSA requested its Scientific Committee to prepare a guidance document providing generic issues and criteria to consider biological relevance, particularly when deciding on whether an observed effect is of biological...